Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
8,445,077
-
Shares change
-
+90,799
-
Total reported value, excl. options
-
$68,825,024
-
Value change
-
-$1,838,933
-
Number of buys
-
22
-
Number of sells
-
16
-
Price
-
$8.15
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q4 2018
As of 31 Dec 2018 Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) had 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,445,077 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Fosun International Ltd, FMR LLC, Vanguard Group Inc, KORNITZER CAPITAL MANAGEMENT INC /KS, BlackRock Inc., GILDER GAGNON HOWE & CO LLC, Point72 Asset Management, L.P., and CONNING INC..
This table shows 41 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.